NCT04983550 2021-07-30
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.